D-0608-2025 Class II Ongoing
FDA drug recall D-0608-2025 was initiated by Boothwyn Pharmacy LLC on Jul 9, 2025 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 186 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 10, 2025
- Initiation Date
- Jul 9, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 186 vials
Product description
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Reason for recall
Subpotent Drug
Distribution pattern
U.S. Nationwide
Code information
03202025@9 BUD 07/18/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0608-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026